479 related articles for article (PubMed ID: 33973730)
1. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway.
Duan J; Jin M; Yang D; Shi J; Gao J; Guo D; Tang H; Zhang S; Qiao B
Bioengineered; 2022 Feb; 13(2):4455-4467. PubMed ID: 35152855
[TBL] [Abstract][Full Text] [Related]
3. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma.
Chen SL; Huang QS; Huang YH; Yang X; Yang MM; He YF; Cao Y; Guan XY; Yun JP
Theranostics; 2020; 10(20):9186-9199. PubMed ID: 32802186
[TBL] [Abstract][Full Text] [Related]
4. Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
Ni Y; Yang Z; Agbana YL; Bai H; Wang L; Yang L; Yi Z; Cheng J; Zhang Q; Kuang Y; Zhu Y
Cancer Sci; 2021 Oct; 112(10):4075-4086. PubMed ID: 34310804
[TBL] [Abstract][Full Text] [Related]
5. UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells.
Ho JY; Lu HY; Cheng HH; Kuo YC; Lee YA; Cheng CH
Cell Oncol (Dordr); 2021 Dec; 44(6):1325-1338. PubMed ID: 34582005
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma.
Huang T; Tian W; Zhou Q; Li J; Jiang Z; Chen J; Ge C; Tian H
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):988-996. PubMed ID: 34133712
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
[TBL] [Abstract][Full Text] [Related]
9. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
10. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
[TBL] [Abstract][Full Text] [Related]
11. ATXN3 promotes proliferation, stemness and motility of clear cell renal cell carcinoma cells by regulating S100A8 ubiquitination.
Bai J; Han J; Fan J; Song J; Wang S
Physiol Int; 2023 Dec; 110(4):311-325. PubMed ID: 37938238
[TBL] [Abstract][Full Text] [Related]
12. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
13. USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling.
Zhao X; Wu X; Wang H; Yu H; Wang J
Mol Carcinog; 2020 Aug; 59(8):1000-1011. PubMed ID: 32511815
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-specific protease-44 inhibits the proliferation and migration of cells via inhibition of JNK pathway in clear cell renal cell carcinoma.
Zhou J; Wang T; Qiu T; Chen Z; Ma X; Zhang L; Zou J
BMC Cancer; 2020 Mar; 20(1):214. PubMed ID: 32164618
[TBL] [Abstract][Full Text] [Related]
16. PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.
Li HL; Han L; Chen HR; Meng F; Liu QH; Pan ZQ; Bai J; Zheng JN
Oncotarget; 2015 Aug; 6(25):21406-20. PubMed ID: 26033551
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
19. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis
Yan F; Wang Q; Xia M; Ru Y; Hu W; Yan G; Xiong X; Zhang M; Wang J; Li Q; Zhang B; Wang H; Lin W; Wu G; Li X
Cancer Biol Med; 2021 Dec; 19(6):818-35. PubMed ID: 34931765
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-Fold Modifier-1 Participates in the Diabetic Inflammatory Response by Regulating NF-κB p65 Nuclear Translocation and the Ubiquitination and Degradation of IκBα.
Hu X; Zhang H; Zhuang L; Jin G; Yang Q; Li M; Sun W; Chen F
Drug Des Devel Ther; 2020; 14():795-810. PubMed ID: 32158197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
